Polymorphism in ftsI gene and β-lactam susceptibility in Portuguese Haemophilus influenzae strains: clonal dissemination of β-lactamase-positive isolates with decreased susceptibility to amoxicillin/clavulanic acid

Journal of Antimicrobial Chemotherapy

Volumn 66, Issue 4, 2011, Pages 788-796

  Barbosa, Ana Raquel ^a   Giufrè, Maria ^b   Cerquetti, Marina ^b   Bajanca Lavado, Maria Paula ^a  

^a NATIONAL INSTITUTE OF HEALTH DR RICARDO JORGE   (Portugal)

^b ISTITUTO SUPERIORE DI SANITÀ   (Italy)

Author keywords

lactamases; Ampicillin resistance; Genetic relatedness; Penicillin binding proteins

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; AMPICILLIN; BETA LACTAMASE; CEFACLOR; CEFEPIME; CEFOTAXIME; CEFUROXIME; GAMMA GLUTAMYLTRANSFERASE; MEROPENEM;

AMINO ACID SUBSTITUTION; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL GENE; BACTERIAL STRAIN; BACTERIUM ISOLATE; CONTROLLED STUDY; FTSI GENE; GENE MUTATION; GENETIC POLYMORPHISM; HAEMOPHILUS INFLUENZAE; MINIMUM INHIBITORY CONCENTRATION; MOLECULAR PHYLOGENY; NONHUMAN; NUCLEOTIDE SEQUENCE; PENICILLIN RESISTANCE; POLYMERASE CHAIN REACTION; PORTUGAL; PROTEIN DOMAIN; PROTEIN MOTIF;

ADOLESCENT; ADULT; AMOXICILLIN-POTASSIUM CLAVULANATE COMBINATION; ANTI-BACTERIAL AGENTS; BACTERIAL PROTEINS; BACTERIAL TYPING TECHNIQUES; BETA-LACTAM RESISTANCE; BETA-LACTAMASES; CHILD; CLUSTER ANALYSIS; DNA, BACTERIAL; ELECTROPHORESIS, GEL, PULSED-FIELD; GENOTYPE; HAEMOPHILUS INFECTIONS; HAEMOPHILUS INFLUENZAE; HUMANS; MICROBIAL SENSITIVITY TESTS; MOLECULAR TYPING; PENICILLIN-BINDING PROTEINS; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; PORTUGAL; SEQUENCE ANALYSIS, DNA;

EID: 79952803282     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkq533     Document Type: Article

References (35)

1. Jansen WT, Veral A, Beitsma M. et al. Longitudinal European surveillance of antibiotic resistance of Haemophilus influenzae. J Antimicrob Chemother 2006; 58: 873-7.
2. Fluit AC, Florijn A, Verhoef J. et al. Susceptibility of European β-lactamase-positive and -negative Haemophilus influenzae isolates from the periods 1997/1998 and 2002/2003. J Antimicrob Chemother 2005; 56: 133-8.
3. Hasegawa K, Chiba N, Kobayashi R. et al. Rapidly increasing prevalence of β-lactamase-nonproducing, ampicillin-resistant Haemophilus influenzae type b in patients with meningitis. Antimicrob Agents Chemother 2004; 48: 1509-14.
4. Sanbongi Y, Suzuki T, Osaki Y. et al. Molecular evolution of β-lactam-resistant Haemophilus influenzae: 9-year surveillance of penicillin-binding protein 3 mutations in isolates from Japan. Antimicrob Agents Chemother 2006; 50: 2487-92.
5. García-Cobos S, Campos J, Lázaro E. et al. Ampicillin-resistant non-β-lactamase-producing Haemophilus influenzae in Spain: recent emergence of clonal isolates with increased resistance to cefotaxime and cefixime. Antimicrob Agents Chemother 2007; 51: 2564-73.
6. Doern GV, Brueggemann AB, Pierce G. et al. Antibiotic resistance among clinical isolates of Haemophilus influenzae in the United States in 1994 and 1995 and detection of β-lactamase-positive strains resistant to amoxicillin-clavulanate: results of a national multicenter surveillance study. Antimicrob Agents Chemother 1997; 41: 292-7.
7. Ubukata K, Shibasaki Y, Yamamoto K. et al. Association of amino acid substitutions in penicillin-binding protein 3 with β-lactam resistance in β-lactamase-negative ampicillin-resistant Haemophilus influenzae. Antimicrob Agents Chemother 2001; 45: 1693-9.
8. Kaczmarek FS, Gootz TD, Dib-Haji F. et al. Genetic and molecular characterization of β-lactamase-negative ampicillin-resistant Haemophilus influenzae with unusually high resistance to ampicillin. Antimicrob Agents Chemother 2004; 48: 1630-9.
9. Hasegawa K, Yamamoto K, Chiba RK. et al. Diversity of ampicillin-resistance genes in Haemophilus influenzae in Japan and the United States. Microbial Drug Resistance 2003; 9: 39-46.
10. Dabernat H, Delmas C, Seguy M. et al. Diversity of β-lactam resistance-conferring amino acid substitutions in penicillin-binding protein 3 of Haemophilus influenzae. Antimicrob Agents Chemother 2002; 46: 2208-18.
11. Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Susceptibility Testing: Nineteenth Informational Supplement M100-S19. CLSI, Wayne, PA, USA, 2009.
12. Mendonça N, Ferreira E, Caniça M. Occurrence of a novel SHV-type enzyme (SHV-55) among isolates of Klebsiella pneumoniae from Portuguese origin in a comparison study for extended-spectrum β-lactamase-producing evaluation. Diagn Microbiol Infect Dis 2006; 56: 415-20.
13. Cerquetti M, Giufré M, Cardines R. et al. First characterization of heterogeneous resistance to imipenem in invasive nontypeable Haemophilus influenzae isolates. Antimicrob Agents Chemother 2007; 51: 3155-61.
14. Campos J, Hernando M, Román F. et al. Analysis of invasive Haemophilus influenzae infections after extensive vaccination against Haemophilus influenzae type b. J Clin Microbiol 2004; 42: 524-9.
15. Tenover FC, Arbeit RD, Goering RV. et al. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J Clin Microbiol 1995; 33: 2233-9.
16. Tristram SG, Jacobs MR, Appelbaum PC. Antimicrobial resistance in Haemophilus influenzae. Clin Microbiol Rev 2007; 20: 368-9.
17. Matic V, Bozdogan B, Jacobs MR. et al. Contribution of β-lactamase and PBP amino acid substitutions to amoxicillin/clavulanate resistance in β-lactamase-positive, amoxicillin/clavulanate-resistant Haemophilus influenzae. J Antimicrob Chemother 2003; 52: 1018-21.
18. Kishii K, Chiba N, Morozumi M. et al. Diverse mutations in the ftsI gene in ampicillin-resistant Haemophilus influenzae isolates from pediatric patients with acute otitis media. J Infect Chemother 2010; 16: 87-93.
19. Kim I, Ki C, Kim S. et al. Diversity of ampicillin resistance genes and antimicrobial susceptibility patterns in Haemophilus influenzae strains isolated in Korea. Antimicrob Agents Chemother 2007; 51: 453-60.
20. Barry AL, Fuchs PC, Brown SD. Identification of β-lactamase-negative, ampicillin-resistant strains of Haemophilus influenzae with four methods and eight media. Antimicrob Agents Chemother 2001; 45: 1585-8.
21. Alou L, Giménez MJ, Sevillano D. et al. Are β-lactam breakpoints adequate to define non-susceptibility for all Haemophilus influenzae resistance phenotypes from a pharmacodynamic point of view? J Antimicrob Chemother 2007; 59: 652-7.
22. Shuel ML, Tsang RSW. Canadian β-lactamase-negative Haemophilus influenzae isolates showing decreased susceptibility toward ampicillin have significant penicillin binding protein 3 mutations. Diagn Microbiol Infect Dis 2009; 63: 379-83.
23. García-Cobos S, Campos J, Román F. et al. Low β-lactamase-negative ampicillin-resistant Haemophilus influenzae strains are best detected by testing amoxicillin susceptibility by the broth microdilution method. Antimicrob Agents Chemother 2008; 52: 2407-14.
24. García-de-Lomas J, Lerma M, Cebrián L. et al. Influence of Haemophilus influenzae β-lactamase production and/or ftsI gene mutations on in vitro activity of and susceptibility rates to aminopenicillins and second- and third-generation cephalosporins. Int J Antimicrob Agents 2007; 30: 190-2.
25. Hoban D, Felmingham D. The PROTEKT surveillance study: antimicrobial susceptibility of Haemophilus influenzae and Moraxella catarrhalis from community-acquired respiratory tract infections. J Antimicrob Chemother 2002; 50 Suppl S1: 49-59.
26. Jacobs MR. Worldwide trends in antimicrobial resistance among common respiratory tract pathogens in children. Pediatric Infect Dis J 2003; 22: S109-19.
27. Garcia-Rodriguez JA, Baquero F, Garcia de Lomas J. et al. Antimicrobial susceptibility of 1,422 Haemophilus influenzae isolates from respiratory tract infections in Spain. Results of a 1-year (1996-97) multicenter surveillance study. Spanish surveillance Group for Respiratory Pathogens. Infection 1999; 27: 265-7.
28. Marco F, Garcia-de Lomas J, Garcia-Rey C. et al. Antimicrobial susceptibilities of 1,730 Haemophilus influenzae respiratory tract isolates in Spain in 1998-1999. Antimicrob Agents Chemother 2001; 45: 3226-8.
29. Sevillano D, Giménez MJ, Cercenado E. et al. Genotypic versus phenotypic characterization, with respect to β-lactam susceptibility, of Haemophilus influenzae isolates exhibiting decreased susceptibility to β-lactam resistance markers. Antimicrob Agents Chemother 2009; 53: 267-70.
30. Tristram SG, Nichols S. A multiplex PCR for β-lactamase genes of Haemophilus influenzae and description of a new blaTEM promoter variant. J Antimicrob Chemother 2006; 58: 183-5.
31. Gazane LC, Delmas C, Bingen E. et al. Molecular epidemiology of ampicillin-resistant non-β-lactamase-producing Haemophilus influenzae. J Clin Microbiol 1998; 36: 3629-35.
32. Karlowsky JA, Critchley IA, Blosser-Middleton RS. et al. Antimicrobial surveillance of Haemophilus influenzae in the United States during 2000-2001 leads to detection of clonal dissemination of a β-lactamase-negative and ampicillin-resistant strain. J Clin Microbiol 2002; 40: 1063-6.
33. Qin L, Watanabe H, Asoh N. et al. Antimicrobial susceptibility and genetic characteristics of Haemophilus influenzae isolated from patients with respiratory tract infections between 1987 and 2000, including β-lactamase-negative ampicillin resistant strains. Epidemiol Infect 2007; 135: 665-8.
34. Takahata S, Takashi I, Senju N. et al. Horizontal gene transfer of ftsI, encoding penicillin-binding protein 3, in Haemophilus influenzae. Antimicrob Agents Chemother 2007; 51: 1589-95.
35. Spratt BG, Bowler LD, Zhang QY. et al. Role of interspecies transfer of chromosomal genes in the evolution of penicillin resistance in pathogenic and commensal Neisseria species. J Mol Evol 1992; 34: 115-25.